Preface
Spotlight on tumor mutational burden in patients with non-small cell lung carcinoma
Translational Lung Cancer Research
2018;
7
(6)
:614-615
.
(01 December 2018)
Original Article
A scalable solution for tumor mutational burden from formalinfixed, paraffin-embedded samples using the Oncomine Tumor Mutation Load Assay
Translational Lung Cancer Research
2018;
7
(6)
:616-630
.
(01 December 2018)
Review Article
Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?
Translational Lung Cancer Research
2018;
7
(6)
:631-638
.
(01 December 2018)
The clinical utility of tumor mutational burden in non-small cell lung cancer
Translational Lung Cancer Research
2018;
7
(6)
:639-646
.
(01 December 2018)
Clinical utility of tumor mutational burden in patients with nonsmall cell lung cancer treated with immunotherapy
Translational Lung Cancer Research
2018;
7
(6)
:647-660
.
(01 December 2018)
Methods of measurement for tumor mutational burden in tumor tissue
Translational Lung Cancer Research
2018;
7
(6)
:661-667
.
(01 December 2018)
Measuring tumor mutation burden in non-small cell lung cancer: tissue versus liquid biopsy
Translational Lung Cancer Research
2018;
7
(6)
:668-677
.
(01 December 2018)
Approach to evaluating tumor mutational burden in routine clinical practice
Translational Lung Cancer Research
2018;
7
(6)
:678-681
.
(01 December 2018)
Predictive markers for anti-PD-1/PD-L1 therapy in non-small cell lung cancer—where are we?
Translational Lung Cancer Research
2018;
7
(6)
:682-690
.
(01 December 2018)
Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC
Translational Lung Cancer Research
2018;
7
(6)
:691-702
.
(01 December 2018)
Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians
Translational Lung Cancer Research
2018;
7
(6)
:703-715
.
(01 December 2018)
Mini-Review
Tumor mutational burden in non-small cell lung cancer—the pathologist’s point of view
Translational Lung Cancer Research
2018;
7
(6)
:716-721
.
(01 December 2018)
Disclosure:
The focused issue “Current Knowledge and Future Perspectives on Tumor Mutational Burden in Non-small Cell Lung Cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Marius Ilie and Paul Hofman served as the unpaid Guest Editors for the focused issue.
